By Bill Foege
In the midst of a global pandemic with COVID-19, we seek lessons from the past and we try to define what leadership instructions might be useful today.
President Trump’s enthusiastic embrace of a malaria drug that he now says he takes daily — and the resulting uproar in the news media — appears to be interfering with legitimate scientific research into whether the medicine might work to prevent coronavirus infection or treat the disease in its early stages.
Juan Osorio-Valencia from the Department of Global Health at the University of Washington Schools of Public Health and Medicine is one of four graduate students from the UW awarded Social Entrepreneurship Fellowships by the Population Health Initiative.
Research projects funded for 2020 by EarthLab’s Innovation Grants Program will study how vegetation might reduce pollution, help an Alaskan village achieve safety and resilience amid climate change, organize a California river’s restoration with tribal involvement, compare practices in self-managed indigenous immigrant communities and more.
The novel coronavirus can severely affect pregnant women who are overweight or obese before becoming pregnant, new research suggests.
Published today by the American Journal of Obstetrics and Gynecology, the findings show that women who contract the virus may have a higher incidence of preterm birth.
The Population Health Initiative today announced the award of six Population Health Applied Research Fellowships to four graduate and two undergraduate students. Eileen Kazura, a Master of Public Health student in the Department of Global Health, was one of the students selected for the fellowship program.
The Department of Global Health recently awarded its 2020 Outstanding Staff Award to Noura Youssoufa (Academic Advisor, MPH and Undergraduate Programs). Her role as Academic Advisor includes working with prospective MPH students – both in-person, online, and at conference recruitment events – as well as organizing Visit Days for all admitted graduate students in the department.
With a new $765,120 grant, Global Health professor Paul Drain will lead a study to develop an antigen-based COVID-19 test – as well as evaluate PCR-based tests and immunological assays – to be used at the point of care. This grant, sponsored by the Bill and Melinda Gates Foundation, is titled “Developing and Evaluating Point-of-Care Antigen and Immunoassays for COVID-19 and Cytokine Release Syndrome among people being screened for SARS-CoV-2 infection in Seattle”.
One of the hottest debates in the coronavirus pandemic is whether the malaria drugs promoted as possible treatments by President Donald Trump really work. But Americans don’t seem overly eager to help answer the question.
Global Health Career Week, in collaboration with the School of Public Health, concluded with a Q&A panel on protecting public health during the COVID-19 pandemic. This live Zoom event provided participants with an opportunity to ask questions to our panel of experts.